← Arcosa, Inc. ACA
Market Price
$145.37
Market Cap
$7.12B
P/E Ratio
N/A
Revenue (FY 2025)
↑12.2% YoY
$2.88B
3-Yr CAGR: 8.7%
Net Income
↑122.4% YoY
$208.40M
Net Margin: 7.2%
Free Cash Flow
↓-43.8% YoY
$175.50M
FCF Yield: 2.47%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
7.9%
ROA: 4.2%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (ACA)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | $1,462.4M | — | $294.7M | $89.7M | — | — | — | $162.0M | $79.6M | — |
| FY 2018 | $1,460.4M | -0.1% | $272.0M | $75.7M | -15.6% | — | — | $118.5M | $73.7M | -7.4% |
| FY 2019 | $1,736.9M | +18.9% | $332.4M | $113.3M | +49.7% | — | — | $358.8M | $273.4M | +271.0% |
| FY 2020 | $1,935.6M | +11.4% | $382.0M | $106.6M | -5.9% | — | — | $259.9M | $177.8M | -35.0% |
| FY 2021 | $2,036.4M | +5.2% | $366.2M | $69.6M | -34.7% | — | — | $166.5M | $81.4M | -54.2% |
| FY 2022 | $2,242.8M | +10.1% | $422.8M | $245.8M | +253.2% | — | — | $174.3M | $36.3M | -55.4% |
| FY 2023 | $2,307.9M | +2.9% | $443.8M | $159.2M | -35.2% | — | — | $261.0M | $57.5M | +58.4% |
| FY 2024 | $2,569.9M | +11.4% | $515.2M | $93.7M | -41.1% | — | — | $502.0M | $312.3M | +443.1% |
| FY 2025 | $2,883.4M | +12.2% | $647.2M | $208.4M | +122.4% | — | — | $341.1M | $175.5M | -43.8% |
Valuation
Market Price
$145.37
Market Cap
$7.12B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
2.70
FCF Yield
2.47%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
22.45%
Operating Margin
11.86%
Net Margin
7.23%
Return on Equity (ROE)
7.89%
Return on Assets (ROA)
4.18%
Asset Turnover
0.58x
Revenue 3-Yr CAGR
8.74%
Financial Health & Liquidity
Current Ratio
2.20
Cash Ratio
0.43
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$214.60M
Total Debt
N/A
Book Value / Share
$53.80
Cash Flow Efficiency
Operating Cash Flow
$341.10M
Capital Expenditures (CapEx)
$165.60M
Free Cash Flow
$175.50M
OCF / Revenue
11.83%
FCF / Revenue
6.09%
FCF 3-Yr CAGR
69.09%
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$53.80
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$4.99B
Total Liabilities
$4.99B
Stockholders' Equity
$2.64B
Current Assets
$1.11B
Current Liabilities
$503.60M